Original Research
Beyond magnesium sulphate – Rethinking magnesium’s impact on maternal and foetal health in low to middle-income countries: A scoping review
Submitted: 14 July 2025 | Published: 13 January 2026
About the author(s)
Naeera Abdul, Department of Laboratory Medicine and Medical Sciences, Faculty of Health Sciences, University of KwaZulu-Natal, Durban, South AfricaVinogrin Dorsamy, Department of Laboratory Medicine and Medical Sciences, Faculty of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
Chauntelle Bagwandeen, School of Public Health and Nursing, Faculty of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
Abstract
Background: Hypertensive disorders of pregnancy (HDP), contribute greatly to maternal and perinatal morbidity and mortality, particularly in low-and middle-income countries (LMICs), undermining progress towards reducing maternal mortality. While magnesium sulphate is established for seizure prophylaxis, magnesium’s physiological and epidemiological significance in HDPs is underexplored. This scoping review mapped current evidence on maternal magnesium homeostasis and HDP association.
Methods: Electronic databases were searched for studies reporting maternal magnesium levels, magnesium physiology in pregnancy or, magnesium supplementation in HDP. Eleven studies met the eligibility inclusion criteria. Data was charted for study design, magnesium biomarkers, outcomes and contextual factors.
Results: Observational evidence demonstrated lower magnesium levels among women with HDP against normotensive controls and linked low magnesium with adverse foetal outcomes. Mechanistic studies supported this, highlighting magnesium’s role in endothelial function, vascular tone regulation and oxidative stress. Randomised trials evaluating magnesium supplementation showed inconsistent findings and were influenced by variations in formulation, dosage, timing and, underlying nutritional status. Contextual factors, such as HIV, obesity, renal function, and socioeconomic disadvantage, impacted magnesium homeostasis and HDP risk, particularly in LMICs.
Conclusion: Magnesium insufficiency may contribute to HDP and adverse perinatal outcomes in LMICs, though causal pathways remain unconfirmed. Improved biomarker standardisation, mechanistic studies, and targeted supplementation trials in high-risk or deficient populations are needed.
Contribution: This review highlights key inconsistencies in magnesium measurement, identifies contextual modifiers relevant to LMICs, and outlines priority areas for future research.
Keywords
Sustainable Development Goal
Metrics
Total abstract views: 342Total article views: 300